Navigating the U.S. regulatory landscape for neurologic digital health technologies
Digital health technologies (DHTs) can transform neurological assessments, improving quality and continuity of care. In the United States, the Food & Drug Administration (FDA) oversees the safety and efficacy of these technologies, employing a detailed regulatory process that classifies devices...
Main Authors: | Neil A. Busis, Dilshad Marolia, Robert Montgomery, Laura J. Balcer, Steven L. Galetta, Scott N. Grossman |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-04-01
|
Series: | npj Digital Medicine |
Online Access: | https://doi.org/10.1038/s41746-024-01098-5 |
Similar Items
-
The use of virtual complementary and integrative therapies by neurology outpatients: An exploratory analysis of two cross-sectional studies assessing the use of technology as treatment in an academic neurology department in New York City
by: Mia T Minen, et al.
Published: (2022-07-01) -
Evaluation of Vascular Neurology Fellowship Websites
in the U.S.
by: Michelle T Tram, et al.
Published: (2024-02-01) -
Deregulating and regulatory reform in the U.S. electric power sector
by: Joskow, Paul L.
Published: (2009) -
Trends in U.S. regulatory approvals of the biopharmaceutical therapeutic entities
by: Graham, James B., 1976-
Published: (2006) -
Review of applicable U.S. Department of Energy and U.S. Nuclear Regulatory Commission activities : Project task 1
by: Apostolakis, G., et al.
Published: (2014)